Shimizu, Y.; Tamada, S.; Kato, M.; Hirayama, Y.; Takeyama, Y.; Iguchi, T.; Sadar, M.D.; Nakatani, T.
Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. J. Clin. Med. 2018, 7, 444.
https://doi.org/10.3390/jcm7110444
AMA Style
Shimizu Y, Tamada S, Kato M, Hirayama Y, Takeyama Y, Iguchi T, Sadar MD, Nakatani T.
Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. Journal of Clinical Medicine. 2018; 7(11):444.
https://doi.org/10.3390/jcm7110444
Chicago/Turabian Style
Shimizu, Yasuomi, Satoshi Tamada, Minoru Kato, Yukiyoshi Hirayama, Yuji Takeyama, Taro Iguchi, Marianne D. Sadar, and Tatsuya Nakatani.
2018. "Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy" Journal of Clinical Medicine 7, no. 11: 444.
https://doi.org/10.3390/jcm7110444
APA Style
Shimizu, Y., Tamada, S., Kato, M., Hirayama, Y., Takeyama, Y., Iguchi, T., Sadar, M. D., & Nakatani, T.
(2018). Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy. Journal of Clinical Medicine, 7(11), 444.
https://doi.org/10.3390/jcm7110444